Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Other financing activities (2016 - 2025)

Orthofix Medical's Other financing activities history spans 15 years, with the latest figure at $19000.0 for Q2 2025.

  • For the quarter ending Q2 2025, Other financing activities fell 97.75% year-over-year to $19000.0, compared with a TTM value of $531000.0 through Dec 2025, down 85.37%, and an annual FY2025 reading of $531000.0, down 85.37% over the prior year.
  • Other financing activities for Q2 2025 was $19000.0 at Orthofix Medical, down from $512000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.9 million in Q4 2021, with the low at -$385000.0 in Q1 2021.
  • Average Other financing activities over 5 years is $454875.0, with a median of $192500.0 recorded in 2022.
  • Year-over-year, Other financing activities skyrocketed 1921.74% in 2023 and then tumbled 97.75% in 2025.
  • Tracing OFIX's Other financing activities over 5 years: stood at $1.9 million in 2021, then tumbled by 91.47% to $160000.0 in 2022, then skyrocketed by 936.25% to $1.7 million in 2023, then plummeted by 38.9% to $1.0 million in 2024, then tumbled by 98.12% to $19000.0 in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Other financing activities are $19000.0 (Q2 2025), $512000.0 (Q1 2025), and $1.0 million (Q4 2024).